Former swimsuit model Kathy Ireland is launching a line of cannabidiol, a.k.a. CBD, products to bolster her existing portfolio of strong brands. Level Brands, Inc. (NYSE:LEVB), Kathy's corporate brand management and consumer products marketing company, has partnered with Vancouver-based Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) for the development side of things, while Level Brands will take care of the branding and marketing.
A Match Made in Heaven
This could be a match made in heaven since Level Brands is a proven leader in brand marketing and promotion, while Isodiol has been rapidly rising to the top of the neutraceutical/phytoceutical CBD space. "Isodiol is an innovative, progressive and pioneering company," says Kathy Ireland, Level Brands' Chairman Emeritus and Chief Brand Strategist.
Ireland continued to mention that, "one of the many responsibilities in this new venture is, for me personally, to serve as Educator in Chief about cannabidiol, and how it is used by Isodiol. This company is leading the strategy of appropriate uses of hemp derivatives, and Isodiol products are free of THC. It's ironic that people find controversy in the powerfully useful hemp plant."
Beside's Isodiol's leadership in the CBD space, Ireland brings a lot of influence to the table. License Global magazine named Ireland one of the 19 most influential women in the licensing industry. Additionally, Ireland has been the subject of multiple Forbes magazine covers, in the U.S. and abroad.
Terms of the Agreement
Under the agreement, Isodiol will work with Level Brands to develop consumer products for kathy ireland® Health & Wellness, a licensor to Level Brands, and for Level Brands subsidiary I'M1, the company's lifestyle brand for men.
Level Brands will receive an initial $2 million USD payment in the form of Isodiol shares and initial cash payments of $62,500 USD due at execution of the licensing agreement and on June 30, 2018. During the term of the agreement Level will also receive $750,000 USD per quarter in the form of Isodiol shares and a 3% royalty on all gross sales of branded products.
The contract term is for an initial five years. Marketing materials were designed and filmed in December of 2017 and both parties intend to finalize all points of the negotiations no later than January 31, 2018.
What to Expect
The new Isodiol kathy ireland® Health & Wellness and I'M1 products are expected to debut in mid to late Spring 2018 and be available online and in select retail stores, and will include body balms, tinctures, personal care, and drinks according to GreenState.
As more information becomes available, we'll be sure to keep investors and consumers updated. In the meantime, be sure to sign up for Isodiol alerts. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!